TGFB1 and pancreatic neoplasm: The functional crosstalk between PAR-2 and TGF-β1 signalling in resistant cells is further suggested by the activation of Akt, which is another downstream mediator of PAR-2 and of the deregulated TGF-β pathway in pancreatic cancer [39].